HMP’s Acquisition Of Provascular GmbH

Heuking Kühn Lüer Wojtek advised HMP on its acquisition of Provascular GmbH. The company announced the establishment of HMP Europe to better leverage growth opportunities on the European market. The agreement with Provascular includes a strategic alliance with the conference organizer, CongO GmbH. In the future, they will jointly organize Leipzig Interventional Course (LINC), a […]

Synova Capital’ Investment In Preventx

Osborne Clarke has advised Synova Capital on its significant minority growth investment into Preventx. Synova will support Preventx and its founders Neil Cooper and Tim Alston to deliver an ambitious growth plan built upon the Business’s excellent reputation, unique integrated technology platform and the supportive dynamics of the growing self-sampling diagnostics market. Preventx was founded […]

Tenzing Private Equity’s Investment In EIKON

Osborne Clarke has advised Tenzing Private Equity on its investment in EIKON. Tenzing has provided significant growth capital to further invest in the company’s state-of-the-art screening facilities in London and Los Angeles, as well as continued software and product development. EIKON, a global specialist in digital mastering and localisation for the entertainment industry, partners with […]

AOK Bundesverband’s Tender Procedure For Communication With Insured Persons

Gleiss Lutz lawyers provided contracting and public procurement advice to the AOK Bundesverband (The Federal Association of the AOK) and the 11 AOKs in the tender procedure for a new content service provider for communication with insured persons. Starting next year, Serviceplan (Berlin) and Heinrich Bauer Verlag (Hamburg) will be new content service providers for […]

EuroEyes International Eye Clinic Limited’s IPO On The Hong Kong Stock Exchange

Eversheds Sutherland advised EuroEyes International Eye Clinic Limited, a Hamburg-headquartered healthcare company, on its initial public offering and listing of shares on the Main Board of the Hong Kong Stock Exchange. The IPO will raise gross proceeds of approximately HK$595.0m (exclusive of the exercise of the over-allotment option). This amount will increase to approximately HK$684.3m […]